Cargando…
POSC102 High-Flow Nasal Cannula in Patients with COVID-19: Is a Cost-Effective Alternative?
Autores principales: | Alves Junior, JM, Villagelin, D, Prota, FE, Chrispim, A, Silva, C, Yamanaka, E, Tagliolatto, R, Beraldo, J, Kater, H, Gomes, J, Freitas, S, Borges, R, Macedo, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769597/ http://dx.doi.org/10.1016/j.jval.2021.11.507 |
Ejemplares similares
-
POSC254 The Impact of COVID-19 on European HTA Decisions
por: Watson, C, et al.
Publicado: (2022) -
Highly fruitful nasal cannula: An innovative use of high flow nasal cannula (HFNC) and a lesson
por: Chowdhury, Sumit Roy, et al.
Publicado: (2022) -
POSC74 Considerations for Mental Health Effects in Health Economic Analyses
por: Dolph, M, et al.
Publicado: (2022) -
Tension Pneumocephalus Induced by Nasal Cannula
por: Xiao, Hao, et al.
Publicado: (2019) -
POSC407 Monitoring of Reported COVID-19 Vaccination Rates in Community Oncology Settings
por: Harrell, R, et al.
Publicado: (2022)